Quick Answer
Regenerative Medical Technology Group Inc. reported Cash And Cash Equivalents At Carrying Value of $530.5 thousand for the year ending 2023.
- Regenerative Medical Technology Group Inc. showed a decrease of -67.8% in Cash And Cash Equivalents At Carrying Value from 2022 to 2023.
- This data is from Regenerative Medical Technology Group Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2024.
- XBRL data for this metric is available from 2016 to 2023 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: $25.8 thousand | Q3 2018: $30.3 thousand | Q1 2019: $578.00 | Q2 2019: $40.1 thousand | Q3 2019: $28.00 | Q4 2019: $23.4 thousand | Q1 2020: $11.4 thousand | Q2 2020: $11.6 thousand | Q3 2020: $59.5 thousand | Q1 2021: $787.7 thousand | Q2 2021: $10.49 million | Q3 2021: $2.53 million | Q4 2021: $2.98 million | Q1 2022: $2.46 million | Q2 2022: $1.92 million | Q4 2023: $530.5 thousand | Q1 2024: $579.4 thousand | Q4 2024: $1.17 million | Q1 2025: $1.22 million | Q2 2025: $1.61 million | Q3 2025: $1.19 million.
- Over the full 8 years of available data (2016 to 2023), Regenerative Medical Technology Group Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 7,880.4%.
- Historical annual values: Fiscal year 2023: $530.5 thousand | Fiscal year 2022: $1.65 million | Fiscal year 2021: $2.98 million | Fiscal year 2020: $42.5 thousand | Fiscal year 2019: $23.4 thousand | Fiscal year 2018: $30.8 thousand | Fiscal year 2017: $7.8 thousand | Fiscal year 2016: $6.6 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: